Nissen et al. found that breast cancer survivors' knowledge about their disease improved after receiving a treatment summary, reporting an increase of 12%, 9%, and 15% in the proportion of patients that correctly identified their disease stage, estrogen receptor status, and progesterone receptor status, respectively, after the intervention.20 The gene discussed is ESR1; the disease is breast carcinoma.